Login / Signup

Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.

Marco SalvettiSibyl WrayGereon NellesNicholas BelvisoAchint KumarThijs KosterWanda Castro-BorreroMegan Vignosnull null
Published in: Multiple sclerosis journal - experimental, translational and clinical (2024)
Peginterferon beta-1a is an effective therapy for managing relapsing multiple sclerosis. The identification of predictors of discontinuation can help inform strategies to enhance treatment persistence.
Keyphrases
  • multiple sclerosis
  • white matter
  • randomized controlled trial
  • systematic review
  • quality improvement
  • cross sectional
  • combination therapy
  • systemic lupus erythematosus
  • replacement therapy